首页> 外国专利> A process for the preparation of adamantanylaminer or 3,5,7-trimethyl homologous or acid addition salts thereof.

A process for the preparation of adamantanylaminer or 3,5,7-trimethyl homologous or acid addition salts thereof.

机译:一种金刚烷胺或其3,5,7-三甲基同源或酸加成盐的制备方法。

摘要

1,274,652. Antidepressant &c. compositions. LILLY INDUSTRIES Ltd. 28 Oct., 1969 [27 Aug., 1968], No. 40968/68. Heading A5B. [Also in Division C2] Pharmaceutical compositions having antidepressant, -Parkinsonism and -motion sickness and appetite suppressant activity comprise, as active ingredient, at least one 1-aminoalkyladamantane of the general formula wherein n is 1 or 2; RSP1/SP is a hydrogen atom or a C 1-4 alkyl group or, when n is 1, RSP1/SP and RSP4/SP together form a methylene group; RSP2/SP is a hydrogen atom or C 1-4 alkyl group or, when n is 1, a C 1-4 hydroxyalkyl or phenyl-C 1- 4 alkyl group, RSP3/SP is a hydrogen atom or a C 1-4 alkyl group or, when RSP2/SP is a hydrogen atom, RSP3/SP is an amidino, pyrimidinyl or C 1-4 alkylpyrimidinyl group, or NRSP2/SPRSP3/SP is a pyrrolidino, piperidino, NC 1-4 alkylpiperazino or N-C 1-4 hydroxyalkylpiperazino group; RSP4/SP is a hydrogen or chlorine atom or a phenyl group or, when n is 1, a bromine atom or cyclohexyl group; RSP5/SP and RSP6/SP are each a hydrogen atom or, when n is 1, a chlorine atom or phenyl group; provided that one of RSP4/SP, RSP5/SP and RSP6/SP is not a chlorine atom and the others are hydrogen atoms or RSP4/SP is not a bromine atom and RSP5/SP and RSP6/SP are hydrogen atoms, when RSP7/SP, RSP8/SP and RSP9/SP are hydrogen atoms, RSP1/SP is a hydrogen atom or a C 1-4 alkyl group, one of RSP2/SP and RSP3/SP is a hydrogen atom and the other is a C 1-4 alkyl group and n is 1; RSP7/SP is a hydrogen or bromine atom or a hydroxyl or -(CH 2 ) n - -CHR a SP1/SP-NR a SP2/SPR a SP3/SP group, wherein n is 1 or 2 and R a SP1/SP, R a SP2/SP and R a SP3/SP are each a hydrogen atom or a C 1-4 alkyl group, or, when n is 1, RSP7/SP is a methyl group; and RSP8/SP and RSP9/SP are each a hydrogen atom or, when n is 1, a methyl group; or pharmaceutically acceptable acid addition salt thereof, in association with a pharmaceutically acceptable carrier.
机译:1,274,652。抗抑郁药成分。 LILLY INDUSTRIES Ltd. 1969年10月28日[1968年8月27日],编号40968/68。标题A5B。 [也在C2部分中]具有抗抑郁,-帕金森病和-晕车和食欲抑制活性的药物组合物包含至少一种通式为n为1或2的1-氨基烷基金刚烷作为活性成分。 R 1 是氢原子或C 1-4烷基,或当n为1时,R 1 和R 4 共同形成一个亚甲基R 2 是氢原子或C 1-4烷基,或者当n为1时是C 1-4羟烷基或苯基-C 1-4烷基,R 3 是氢原子或C 1-4烷基,或当R 2 是氢原子时,R 3 是a基,嘧啶基或C 1-4烷基嘧啶基或NR 2 R 3 是吡咯烷基,哌啶子基,NC 1-4烷基哌嗪子基或NC 1-4羟基烷基哌嗪子基; R 4 为氢或氯原子或苯基,或当n为1时为溴原子或环己基; R 5 和R 6 分别为氢原子或n为1时的氯原子或苯基。前提是R 4 ,R 5 和R 6 中的一个不是氯原子,其他是氢原子或R 4 不是溴原子,R 5 和R 6 是氢原子,而R 7 ,R 8 < / SP>和R 9 是氢原子,R 1 是氢原子或C 1-4烷基,R 2 之一R 3 为氢原子,另一个为C 1-4烷基,n为1。 R 7 是氢或溴原子或羟基或-(CH 2)n--CHR a 1 -NR a 2 R a 3 组,其中n为1或2,R a 1 ,R a 2 和R a 3 分别为氢原子或碳数为1〜4的烷基,或者,当n为1时,R SP 7为甲基。 R 8 和R 9 分别为氢原子或n为1时的甲基。或其药学上可接受的酸加成盐,以及药学上可接受的载体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号